Cargando…
Use of granulocyte colony‐stimulating factor in the treatment of methimazole‐induced agranulocytosis: a case report
A comparison of this case to previously published reports suggests that granulocyte colony‐stimulating factor may be associated with improved prognosis in severe antithyroid drug‐induced neutropenia, and that weight‐based doses could be an appropriate strategy.
Autores principales: | Birmingham, Asha, Mancuso, Carissa, Williams, Craig |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628249/ https://www.ncbi.nlm.nih.gov/pubmed/29026576 http://dx.doi.org/10.1002/ccr3.1124 |
Ejemplares similares
-
Two Cases of Methimazole-Induced Agranulocytosis With Their Risk Factors
por: Khine, Aye, et al.
Publicado: (2021) -
Successful Treatment of Methimazole-Induced Severe Aplastic Anemia by Granulocyte Colony-Stimulating Factor, Methylprednisolone, and Cyclosporin
por: Honda, Munehiro
Publicado: (2011) -
Agranulocytosis with tonsillitis associated with methimazole therapy
por: Zambrana, Jorge T., et al.
Publicado: (2015) -
Severe Drug-Induced Agranulocytosis Successfully Treated with Recombinant Human Granulocyte Colony-Stimulating Factor
por: Kubota, Yohei, et al.
Publicado: (2018) -
SAT-600 Relapse of Agranulocytosis after Recovery of Methimazole-Induced Agranulocytosis
por: Choi, Dughyun, et al.
Publicado: (2019)